Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01930214 · ClinicalTrials.gov registry record
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 350
- Enrollment target
NCT01930214 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 350 participants.
The verdict
NCT01930214 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
The objective of this study is to assess the current standard of care treatment outcome in none/mild, moderate and severely calcified coronary lesions using: * A composite of MACE at 30-day and one (1) year post procedure, and * Procedural and lesion success
Interventions
- DEVICE Percutaneous Coronary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2013-09-26 |
| Est. Completion | 2017-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01930214
The ClinicalTrials.gov registry entry for NCT01930214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous Coronary Intervention is the first listed.
NCT01930214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01930214 about?
NCT01930214 is a clinical study titled "Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)". The objective of this study is to assess the current standard of care treatment outcome in none/mild, moderate and severely calcified coronary lesions using: * A composite of MACE at 30-day and one (1) year post procedure, and * Procedural and lesion success
What is the current status of trial NCT01930214?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2013-09-26. Estimated completion is 2017-06-01.
What interventions are being tested in trial NCT01930214?
The interventions under investigation include: Percutaneous Coronary Intervention (DEVICE).
Who is sponsoring clinical trial NCT01930214?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.